Dexamethasone intravitreal implant at the time of cataract surgery in eyes with diabetic macular edema

European Journal of Ophthalmology

Volumn 27, Issue 4, 2017, Pages 433-437

  Panozzo, Giacomo A ^a   Gusson, Elena ^b   Panozzo, Giorgio ^c   Dalla Mura, Giulia ^a  

^a Bussolengo Hospital   (Italy)

^b University School of Medicine   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

Cataract; Dexamethasone intravitreal implant; Diabetic macular edema; Phacoemulsification

Indexed keywords

ANTIBIOTIC AGENT; DEXAMETHASONE; HEMOGLOBIN A1C; STEROID; DELAYED RELEASE FORMULATION; DRUG IMPLANT; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; CENTRAL FOVEAL THICKNESS; CLINICAL ARTICLE; DIABETIC MACULAR EDEMA; DRUG DELIVERY SYSTEM; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; HUMAN; INTRAOCULAR PRESSURE; INTRAOPERATIVE PERIOD; INTRAVITREAL IMPLANT; LENS IMPLANT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHACOEMULSIFICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; COMPLICATION; DELAYED RELEASE FORMULATION; DIABETIC RETINOPATHY; DRUG IMPLANT; INTRAVITREAL DRUG ADMINISTRATION; LENS IMPLANTATION; MACULAR EDEMA; MIDDLE AGED; PATHOPHYSIOLOGY; PERIOPERATIVE PERIOD; PHYSIOLOGY;

AGED; DELAYED-ACTION PREPARATIONS; DEXAMETHASONE; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DRUG IMPLANTS; FEMALE; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; LENS IMPLANTATION, INTRAOCULAR; MACULAR EDEMA; MALE; MIDDLE AGED; PERIOPERATIVE PERIOD; PHACOEMULSIFICATION; PROSPECTIVE STUDIES; VISUAL ACUITY;

EID: 85024090257     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.5301/ejo.5000920     Document Type: Article

References (34)

1. Klein BE, Klein R, Moss SE. Incidence of cataract surgery in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Am J Ophthalmol. 1995;119(3):295-300.
2. Klein BE, Klein R, Wang Q, Moss SE. Older-onset diabetes and lens opacities. The Beaver Dam Eye Study. Ophthalmic Epidemiol. 1995;2(1):49-55.
3. Foster PJ, Wong TY, Machin D, Johnson GJ, Seah SK. Risk factors for nuclear, cortical and posterior subcapsular cataracts in the Chinese population of Singapore: the Tanjong Pagar Survey. Br J Ophthalmol. 2003;87(9):1112-1120.
4. Nirmalan PK, Robin AL, Katz J, et al. Risk factors for age related cataract in a rural population of southern India: the Aravind Comprehensive Eye Study. Br J Ophthalmol. 2004;88(8):989-994.
5. Raman R, Pal SS, Adams JS, Rani PK, Vaitheeswaran K, Sharma T. Prevalence and risk factors for cataract in diabetes: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study, report no. 17. Invest Ophthalmol Vis Sci. 2010; 51(12):6253-6261.
6. Olafsdottir E, Andersson DK, Stefánsson E. The prevalence of cataract in a population with and without type 2 diabetes mellitus. Acta Ophthalmol. 2012;90(4):334-340. Published online December 16, 2011.
7. Sayin N, Kara N, Pekel G. Ocular complications of diabetes mellitus. World J Diabetes. 2015;6(1):92-108.
8. Hamilton AMP, Ulbig MW. Polkinghorne. Management of diabetic retinopathy. London 1996: BMJ Publishing Group; 19-23.
9. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. Lancet. 2016;387(100027): 1513-30.
10. Baker CW, Almukhtar T, Bressler NM, et al; Diabetic Retinopathy Clinical Research Network Authors/Writing Committee. Macular edema after cataract surgery in eyes without preoperative central-involved diabetic macular edema. JAMA Ophthalmol. 2013;131(7):870-879.
11. Dowler JGF, Sehmi KS, Hykin PG, Hamilton AM. The natural history of macular edema after cataract surgery in diabetes. Ophthalmology. 1999;106(4):663-668.
12. Giocanti-Aurégan A, Grenet T, Fajnkuchen F, Chaine G. (Impact of cataract surgery on central macular thickness in diabetic patients without diabetic retinopathy). J Fr Ophtalmol. 2013; 36(1):35-40.
13. Sadiq SA, Sleep T, Amoaku WM. The visual results and changes in retinopathy in diabetic patients following cataract surgery. Eur J Ophthalmol. 1999;9(1):14-20.
14. Chung J, Kim MY, Kim HS, Yoo JS, Lee YC. Effect of cataract surgery on the progression of diabetic retinopathy. J Cataract Refract Surg. 2002;28(4):626-630.
15. Pollack A, Dotan S, Oliver M. Progression of diabetic retinopathy after cataract extraction. Br J Ophthalmol. 1991;75(9):547-551.
16. Henricsson M, Heijl A, Janzon L. Diabetic retinopathy before and after cataract surgery. Br J Ophthalmol. 1996;80(9): 789-793.
17. Chylack LT Jr, Wolfe JK, Singer DM, et al; The Longitudinal Study of Cataract Study Group. The lens opacities classification system III. Arch Ophthalmol. 1993;111(6):831-836.
18. Panozzo G, Gusson E, Panozzo G, Dalla Mura G. Dexamethasone intravitreal implant for diabetic macular edema: indications for a PRN regimen of treatment. Eur J Ophthalmol. 2015; 25(4):347-351.
19. Jaffe GJ, Burton TC. Progression of nonproliferative diabetic retinopathy following cataract extraction. Arch Ophthalmol. 1988;106(6):745-749.
20. Baker CW, Almukhtar T, Bressler NM, et al; Diabetic Retinopathy Clinical Research Network Authors/Writing Committee. Macular edema after cataract surgery in eyes without preoperative central-involved diabetic macular edema. JAMA Ophthalmol. 2013;131(7):870-879.
21. Chu CJ, Johnston RL, Buscombe C, Sallam AB, Mohamed Q, Yang YC; United Kingdom Pseudophakic Macular Edema Study Group. Risk Factors and Incidence of Macular Edema after Cataract Surgery: A Database Study of 81984 Eyes. Ophthalmology. 2016;123(2):316-323. Published online December 8, 2015.
22. Chae JB, Joe SG, Yang SJ, et al. Effect of combined cataract surgery and ranibizumab injection in postoperative macular edema in nonproliferative diabetic retinopathy. Retina. 2014; 34(1):149-156.
23. Rauen PI, Ribeiro JA, Almeida FP, Scott IU, Messias A, Jorge R. Intravitreal injection of ranibizumab during cataract surgery in patients with diabetic macular edema. Retina. 2012;32(9): 1799-1803.
24. Salehi A, Beni AN, Razmjoo H, Beni ZN. Phacoemulcification with intravitreal bevacizumab injection in patients with cataract and coexisting diabetic retinopathy: prospective randomized study. J Ocul Pharmacol Ther. 2012;28(3):212-218.
25. Wahab S, Ahmed J. Management of cataract with macular oedema due to diabetes mellitus type-II and hypertension with grid laser prior to surgery and intra-vitreal bevacizumab (Avastin) peroperatively. J Pak Med Assoc. 2010;60(10):836-839.
26. Akinci A, Muftuoglu O, Altınsoy A, Ozkılıc E. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract. Retina. 2011;31(4):755-758.
27. Kuppermann BD, Blumenkranz MS, Haller JA, et al; Dexamethasone DDS Phase II Study Group. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol. 2007;125(3):309-317.
28. Furino C, Boscia F, Recchimurzo N, Sborgia C, Alessio G. Intravitreal dexamethasone implant for macular edema following uncomplicated phacoemulsification. Eur J Ophthalmol. 2014;24(3):387-391.
29. Khurana RN, Palmer JD, Porco TC, Wieland MR. Dexamethasone intravitreal implant for pseudophakic cystoid macular edema in patients with diabetes. Ophthalmic Surg Lasers Imaging Retina. 2015;46(1):56-61.
30. Agarwal A, Gupta V, Ram J, Gupta A. Dexamethasone intravitreal implant during phacoemulsification. Ophthalmology. 2013;120(1):211, 211.e1-211.e5.
31. Boyer DS, Yoon YH, Belfort R Jr, et al; Ozurdex MEAD Study Group. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology. 2014;121(10):1904-1914.
32. Haller JA, Bandello F, Belfort R Jr, et al; OZURDEX GENEVA Study Group. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010;117(6): 1134-1146.e3.
33. Augustin AJ, Kuppermann BD, Lanzetta P, et al; Ozurdex MEAD Study Group. Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study. BMC Ophthalmol. 2015; 15:150.
34. Gusson E, Panozzo G, Casati S. Dexamethasone intravitreal implant at the time of cataract surgery in patients with macular edema. Invest Ophthalmol Vis Sci. 2013;54(15):2384.